COL18A1 and non-small cell lung carcinoma: Currently, recombinant endostatin (Endostar) has been approved for the treatment of NSCLC by the State Food and Drug Administration of China, which is expressed and purified in E. coli with an additional nine-amino acid sequence (Hu et al., 2014).